Stockscreener 앱 받기
9.62
0.63%
0.06
시장 영업 전:
9.68
0.06
+0.62%
전일 마감가:
$9.56
열려 있는:
$9.54
하루 거래량:
11.93M
Relative Volume:
1.25
시가총액:
$11.22B
수익:
$14.33B
순이익/손실:
$-3.79B
주가수익비율:
-3.0347
EPS:
-3.17
순현금흐름:
$1.84B
1주 성능:
-6.05%
1개월 성능:
-9.33%
6개월 성능:
+4.00%
1년 성능:
-18.61%
1일 변동 폭
$9.52
$9.86
1주일 범위
$9.49
$10.38
52주 변동 폭
$6.85
$13.55
비아트리스 Stock (VTRS) Company Profile
명칭
Viatris Inc
전화
(724) 514-1465
주소
1000 MYLAN BOULEVARD, CANONSBURG
VTRS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
9.62 | 11.15B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
146.93 | 65.35B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.09 | 47.75B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.40 | 41.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.38 | 21.43B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
403.68 | 18.00B | 2.99B | 1.21B | 1.13B | 25.06 |
비아트리스 Stock (VTRS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-06 | 개시 | Goldman | Neutral |
| 2024-07-19 | 재개 | Jefferies | Buy |
| 2023-10-23 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-06-23 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2023-04-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2023-02-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-10 | 업그레이드 | UBS | Sell → Neutral |
| 2022-11-08 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | 재개 | Jefferies | Hold |
| 2022-06-14 | 개시 | UBS | Sell |
| 2022-05-10 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-01 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | 개시 | Citigroup | Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2021-03-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-03-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | 개시 | Argus | Hold |
| 2020-12-14 | 개시 | Bernstein | Mkt Perform |
모두보기
비아트리스 주식(VTRS)의 최신 뉴스
Viatris (VTRS) Recovers Slightly But Struggles Amid Market Conce - GuruFocus
Day 7 of Loss Streak for Viatris Stock with -9% Return (vs. -20% YTD) [9/16/2025] - Trefis
Market Moves: Is now the right time to enter Viatris IncJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - خودرو بانک
Viatris Inc. (VTRS) Enters $515M IV Iron Market With FDA Green Light - MSN
Aug Swings: Is now the right time to enter Viatris IncJuly 2025 Spike Watch & Target Return Focused Picks - خودرو بانک
Market Leaders: Can Viatris Inc. navigate macro headwindsQuarterly Profit Report & Consistent Return Strategy Ideas - خودرو بانک
Viatris chief commercial officer Le Goff sells $72k in stock - Investing.com Nigeria
Viatris chief commercial officer Le Goff sells $72k in stock By Investing.com - Investing.com South Africa
Real time scanner hits for Viatris Inc. explainedMarket Trend Review & Low Risk Profit Maximizing Plans - Newser
Viatris Investors Face Skeptical Judges on Biosimilars Unit (1) - Bloomberg Law News
US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche - Yahoo Finance
Viatris receives FDA warning letter for 11 drugs made at India plant - MSN
Trend analysis for Viatris Inc. this weekTreasury Yields & Stepwise Trade Signal Guides - Newser
Is Viatris Inc. Starting a New UptrendEarnings Summary Report & Reliable Momentum Entry Alerts - beatles.ru
Viatris Inc. Forms Double Bottom Pattern — Eyes on Breakout2025 Market WrapUp & Fast Moving Market Watchlists - beatles.ru
What makes Viatris Inc. stock attractive to long term investorsQuarterly Trade Report & AI Forecasted Stock Moves - beatles.ru
Is Viatris Inc. reversing from oversold territoryPortfolio Performance Summary & Consistent Growth Equity Picks - Newser
Custom strategy builders for tracking Viatris Inc.July 2025 Summary & Free Long-Term Investment Growth Plans - Newser
Stock Analysis | Viatris OutlookA Technical Bear Market with Mixed Fundamentals - AInvest
Candlestick signals on Viatris Inc. stock todayJuly 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - Newser
How volatile is Viatris Inc. stockJuly 2025 Action & Free High Accuracy Swing Entry Alerts - خودرو بانک
Will a bounce in Viatris Inc. offer an exitJuly 2025 Short Interest & Weekly Top Performers Watchlists - Newser
When is the best time to exit Viatris Inc.Weekly Stock Analysis & Verified Chart Pattern Signals - Newser
Generic Drugs Market is expected to reach US$ 942.69 billion - openPR.com
How to escape a deep drawdown in Viatris Inc.Earnings Risk Summary & Smart Swing Trading Alerts - Newser
What high frequency data says about Viatris Inc.2025 Institutional Moves & Detailed Earnings Play Strategies - Newser
How to use a screener to detect Viatris Inc. breakoutsVolume Spike & Expert Curated Trade Setups - Newser
Fda discontinues manufacture of Dymista, nasal spray, 137 ug 50 ug - MarketScreener
How to use Fibonacci retracement on Viatris Inc.2025 Earnings Surprises & Weekly Return Optimization Alerts - Newser
Zacks Investment Ideas feature highlights: Church & Dwight, Eli Lilly and Viatris - sharewise.com
Using economic indicators to assess Viatris Inc. potential2025 Risk Factors & Expert Curated Trade Setups - Newser
Risk adjusted return profile for Viatris Inc. analyzedGold Moves & Verified Momentum Stock Alerts - Newser
How moving averages guide Viatris Inc. trading2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Using fundamentals and technicals on Viatris Inc.Earnings Recap Report & Expert Approved Momentum Trade Ideas - Newser
Evaluating Viatris Inc. with trendline analysisEarnings Performance Report & Safe Capital Growth Trade Ideas - Newser
Statistical indicators supporting Viatris Inc.’s strengthStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
Can machine learning forecast Viatris Inc. recovery2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser
Using data tools to time your Viatris Inc. exitJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
Can Viatris Inc. recover in the next quarterCPI Data & Expert Approved Momentum Ideas - Newser
Is Viatris Inc. a cyclical or defensive stockJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - خودرو بانک
What are the risks of holding Viatris Inc.Weekly Risk Summary & Low Volatility Stock Suggestions - خودرو بانک
Is Viatris Inc. stock a top performer YTDQuarterly Risk Review & Fast Exit and Entry Trade Guides - خودرو بانک
Can Viatris Inc. deliver consistent EPS growthJuly 2025 Review & Stepwise Trade Signal Guides - خودرو بانک
비아트리스 (VTRS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.88%
1.07%
자본화:
|
볼륨(24시간):